U.S. Marine and Shipping Stock News

NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital Targets AI Trust Layer With xAI Tie Up And VPN For Agents

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

Ultra Clean Updates Board Leadership As AI Cycle Shapes Capital Choices

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

Why TTM Technologies (TTMI) Is Up 6.7% After Record Q1 Results And Higher AI-Defense Outlook

In late April 2026, TTM Technologies reported record first-quarter 2026 results with net sales of US$845.98 million and net income of US$49.99 million, and issued second-quarter guidance calling for net sales between US$930 million and US$970 million. The company highlighted that robust demand tied to artificial intelligence data center buildouts and defense-related programs now underpins the majority of its revenue base, supporting record non-GAAP earnings and higher capital investment...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Valuation Check After Advancing Zovegalisib Combination Into Phase 3 Development

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...
NYSE:OFG
NYSE:OFGBanks

Assessing OFG Bancorp (OFG) Valuation After Q1 Beat And Digital First Progress

Q1 results and digital-first push in focus for OFG Bancorp (OFG) OFG Bancorp (OFG) has been in focus after first quarter results topped Wall Street expectations, with management pointing to ongoing loan growth, steady credit performance, and disciplined expense management. See our latest analysis for OFG Bancorp. The share price has gained 11.3% over the past month and 13.5% over the past quarter. The 1 year total shareholder return of 13.8% and 3 year total shareholder return, which is about...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings’ Long Ridge Deal Recasts Bitcoin Miner As AI Power Player

MARA Holdings (NasdaqCM:MARA) has agreed to acquire Long Ridge Energy & Power LLC for about US$1.5b. The deal includes a 505 MW gas plant and 1,600 acres in Ohio, expanding MARA's owned and operated power capacity by about 65%. The acquisition is expected to close in the second half of 2026, with initial AI and high performance computing capacity targeted for mid 2028. MARA Holdings, best known for its bitcoin mining operations, is moving deeper into power and digital infrastructure with...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Is Beyond Meat’s (BYND) Army Ration Interest Quietly Reshaping Its Risk Profile And Brand Story?

Beyond Meat recently expanded its retail footprint by rolling out Beyond Chicken Pieces Spicy Buffalo to more than 2,000 Kroger stores across the U.S., while the U.S. Army signaled interest in plant-based proteins for future field rations. These developments highlight how product innovation and potential government demand could interact with Beyond Meat’s existing efforts to refine its portfolio and operations. We’ll now examine how the U.S. Army’s interest in plant-based protein could...
NYSE:PHIN
NYSE:PHINAuto Components

Assessing PHINIA (PHIN) Valuation After Strong 1 Year Total Shareholder Return

Recent trading in PHINIA (PHIN) has drawn attention after the stock’s 1 year total return reached 80.31%, prompting investors to look more closely at its current valuation, profitability, and growth profile. See our latest analysis for PHINIA. At a share price of $74.02, PHINIA’s recent 1 month share price return of 6.32% and year to date share price return of 14.49% sit alongside a 1 year total shareholder return of 80.31%. Investors are now weighing this momentum against its valuation and...
NYSE:RRC
NYSE:RRCOil and Gas

How Q1 2026 Earnings Strength and Vanguard’s Stake At Range Resources (RRC) Has Changed Its Investment Story

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Is Arrowhead Pharmaceuticals (ARWR) Stock Price Out Of Line With Recent 1-Year Surge?

If you are wondering whether Arrowhead Pharmaceuticals' current share price lines up with its fundamentals, this article walks through the key valuation angles that matter to you. The stock last closed at US$74.81, with returns of 1.2% over 7 days, 18.9% over 30 days, 10.4% year to date, 418.8% over 1 year and 80.8% over 3 years, compared with 12.7% over 5 years. Recent market focus around Arrowhead Pharmaceuticals has centred on its position in the biopharmaceutical space and ongoing...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel’s Apple And Google Chip Deals Confront Rich Valuation And Dilution Risks

Intel is reportedly close to securing major chip fabrication and advanced packaging deals with Apple and Google, with production expected to start next year. Apple is said to be targeting Intel's 18A P process for future M series chips. Google is reportedly planning to use Intel's EMIB advanced packaging for upcoming TPU hardware. For investors watching NasdaqGS:INTC, these potential deals add a new angle to a stock that has already seen strong recent momentum. The shares currently trade at...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Valuation Check After Strong EPS Surge And Revenue Growth Spurs Investor Interest

Operational momentum behind recent price move Hecla Mining (HL) recently drew investor attention after a very large year over year jump in earnings per share and a 79.5% rise in quarterly revenue, alongside higher next quarter EPS estimates. See our latest analysis for Hecla Mining. Despite the latest 0.22% 1-day share price return and recent short-term weakness, Hecla Mining’s very large 1-year total shareholder return of 298.47% signals that momentum has been building over a longer...
NYSE:PRM
NYSE:PRMChemicals

Evaluating Perimeter Solutions (PRM) After Analyst Upgrades And Strong Momentum-Driven Repricing

Recent analyst upgrades and favorable momentum scores have put Perimeter Solutions (PRM) back on many watchlists, with positive earnings estimate revisions and strong industry relative share performance drawing fresh attention from investors. See our latest analysis for Perimeter Solutions. The recent 17.74% 1 month share price return, together with a very large 1 year total shareholder return of around 3x, suggests momentum is building as investors reassess Perimeter Solutions at a last...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

How Investors Are Reacting To CleanSpark (CLSK) Using Bitcoin Mining Cash To Build AI-Ready Data Centers

In recent months, CleanSpark reported rapid growth in Bitcoin mining output, expanded its hashrate to 50 EH/s, and closed the acquisition of a second Texas data center campus adding 300 megawatts of power capacity to support both mining and AI or cloud workloads. An interesting angle for investors is how CleanSpark is using cash flow from Bitcoin mining to build a Bitcoin treasury while reinvesting into power-heavy data center infrastructure that can serve high-performance computing demand...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Pipeline Wins And Dividend Hike Might Change The Case For Investing In Johnson & Johnson (JNJ)

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...
NYSE:NJR
NYSE:NJRGas Utilities

Is It Too Late To Consider New Jersey Resources (NJR) After Its Strong Multi Year Run?

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...
NYSE:IVZ
NYSE:IVZCapital Markets

Assessing Invesco (IVZ) Valuation After First Quarter 2026 Earnings And Capital Return Updates

Why Invesco’s latest quarter matters for shareholders Invesco (IVZ) just reported first quarter 2026 results, with revenue of US$1,744.5 million and net income of US$268.6 million, alongside continued net long term inflows and record assets under management in China. See our latest analysis for Invesco. At a share price of US$25.89, Invesco’s recent 6.46% 1 month share price return and 1.49% 7 day gain contrast with a weaker 90 day share price return of 5.13% and a year to date share price...
NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO) Valuation Check After Recent Share Price Softness

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...
NYSE:CRI
NYSE:CRILuxury

A Look At Carters (CRI) Valuation After Recent Share Price Weakness

Recent performance snapshot Carter's (CRI) has drawn attention after recent share price moves, with the stock down about 7% over the past week and roughly 5% over the past month, compared with a smaller 3% decline over the past 3 months. See our latest analysis for Carter's. With the share price at $33.71, Carter's recent 1 day share price return of a 6.67% decline and 7 day return of a 9.38% decline sit against a relatively modest 1 year total shareholder return of a 0.34% decline and a much...
NYSE:NFG
NYSE:NFGGas Utilities

A Look At National Fuel Gas (NFG) Valuation As Long Term Returns Contrast With Recent Weakness

National Fuel Gas (NFG) has recently drawn investor attention after its share price closed at $82.98, with recent returns showing mixed moves over the past week, month, and past 3 months. Investors may now reassess its fundamentals. See our latest analysis for National Fuel Gas. The recent 1 day share price return of negative 1.66% extends a short term pullback, with the 30 day share price return of negative 10.65% contrasting with a 5 year total shareholder return of 84.62%. This suggests...
NYSE:BE
NYSE:BEElectrical

Why Bloom Energy (BE) Is Up 25.7% After Oracle AI Deal And Higher 2026 Revenue Outlook

In late April 2026, Bloom Energy reported first‑quarter revenue of US$751.05 million and net income of US$70.65 million, and raised its full‑year 2026 revenue outlook to US$3.40–3.80 billion. Oracle’s decision to power its Project Jupiter AI data center campus entirely with Bloom fuel cells, replacing gas turbines and diesel generators, highlights Bloom’s emerging role as a dedicated power provider for energy‑hungry AI infrastructure. We’ll now examine how Bloom’s upgraded 2026 revenue...
NYSE:HII
NYSE:HIIAerospace & Defense

Ingalls Workforce And Frigate Contracts Shape Huntington Ingalls Valuation Story

Ingalls Shipbuilding is expanding its Shipbuilder Academy workforce program to deepen its pipeline of skilled trades for future shipbuilding needs. The division has also secured new work tied to the U.S. Navy's next generation FF(X) class frigates, adding fresh contract support to its order book. These developments come as investors reassess Huntington Ingalls Industries, NYSE:HII, around its core shipbuilding capabilities and long term execution capacity. For investors tracking Huntington...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

FDA Priority Review For New HIV Combo Might Change The Case For Investing In Gilead Sciences (GILD)

Gilead Sciences, Inc. recently announced that the FDA accepted its New Drug Application for an investigational once-daily single-tablet HIV regimen combining bictegravir 75 mg and lenacapavir 50 mg for virologically suppressed adults, granting priority review with a PDUFA action date of August 27, 2026, based on positive Phase 3 ARTISTRY-1 and ARTISTRY-2 data. The filing underscores Gilead’s efforts to refresh its core HIV portfolio with a compact regimen that maintained virological...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Commerce Bancshares (CBSH) Valuation Check After FineMark Integration Costs And Analyst Downgrades

Commerce Bancshares (CBSH) is under scrutiny after missing first quarter revenue expectations and reporting higher than expected integration costs tied to its FineMark Holdings acquisition, with insider selling and cautious analyst commentary adding further pressure. See our latest analysis for Commerce Bancshares. Over the past year, Commerce Bancshares’ share price has been under pressure, with short term momentum soft despite a 5.58% 1 month share price return and a 1 year total...